Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells

Endocrine-Related Cancer

Volumn 18, Issue 4, 2011, Pages 413-428

  Knight, Brandi B ^a   Oprea Ilies, Gabriela M ^a   Nagalingam, Arumugam ^a   Yang, Lily ^a   Cohen, Cynthia ^a   Saxena, Neeraj K ^b   Sharma, Dipali ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LEPTIN; NOTCH1 RECEPTOR; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOMA CELL; CELL LINE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CLONOGENESIS; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATIN IMMUNOPRECIPITATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INHIBITOR OF APOPTOSIS PROTEINS; LEPTIN; MICE; MICE, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION; WOUND HEALING;

EID: 80052158404     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0075     Document Type: Article

References (58)

1. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C et al. 2000 Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96 1921-1925Pubitemid 30661078)
2. Ahima RS & Osei SY 2004 Leptin signaling. Physiology & Behavior 81 223-241. (doi:10.1016/j.physbeh.2004.02.014)
3. Altieri DC 2003 Validating survivin as a cancer therapeutic target. Nature Reviews. Cancer 3 46-54. (doi:10.1038/nrc968)
4. Altieri DC 2004 Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. Journal of Cellular Biochemistry 92 656-663. (doi:10.1002/jcb.20140)
5. Ambrosini G, Adida C & Altieri DC 1997 A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine 3 917-921. (doi:10.1038/nm0897-917)
6. Andersen MH & thor SP 2002 Survivin - a universal tumor antigen. Histology and Histopathology 17 669-675.
7. Aoki Y, Feldman GM & Tosato G 2003 Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101 1535-1542. (doi:10.1182/blood-2002-07-2130)
8. Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, SatoM & Sato N 2005 Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Research 65 11018-11025. (doi:10.1158/0008-5472.CAN-05-0491)
9. Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, Lindtner J, Erien D, Collins J et al. 2004 Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Annals of Oncology 15 875-884. (doi:10.1093/annonc/ mdh222)
10. Callahan R & Raafat A 2001 Notch signaling in mammary gland tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 6 23-36. (doi:10.1023/A:1009512414430)
11. Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K et al. 2000 Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2 235-241. (doi:10.1038/sj.neo.7900091)
12. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, ChenHY, HouMF&Yuan SS 2006 Serumadiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Letters 237 109-114. (doi:10.1016/j.canlet.2005.05.047)
13. Cirillo D, Rachiglio AM, la Montagna R, Giordano A &Normanno N 2008 Leptin signaling in breast cancer: an overview. Journal of Cellular Biochemistry 105 956-964. (doi:10.1002/jcb.21911)
14. Dan HC, Jiang K, Coppola D, Hamilton A, Nicosia SV, Sebti SM & Cheng JQ 2004 Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis. Oncogene 23 706-715. (doi:10.1038/sj.onc.1207171)
15. Dievart A, Beaulieu N & Jolicoeur P 1999 Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 18 5973-5981. (doi:10.1038/sj.onc.1202991)
16. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S &Surmacz E 2006 Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clinical Cancer Research 12 1447-1453. (doi:10.1158/1078-0432.CCR-05-1913)
17. Gonzalez RR & Leavis P 2001 Leptin upregulates beta3-integrin expression and interleukin-1beta, upregulates leptin and leptin receptor expression in human endometrial epithelial cell cultures. Endocrine 16 21-28. (doi:10.1385/ENDO:16:1:21)
18. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T et al. 2006 Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). Journal of Biological Chemistry 281 26320-26328. (doi:10.1074/jbc.M601991200)
19. Gupta GP & Massague J 2006 Cancer metastasis: building a framework. Cell 127 679-695. (doi:10.1016/j.cell.2006.11.001)
20. Higashiyama S, Iwabuki H, Morimoto C, Hieda M, Inoue H & Matsushita N 2008 Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Science 99 214-220. (doi:10.1111/j.1349-7006. 2007.00676.x)
21. Hoffman WH, Biade S, Zilfou JT, Chen J & Murphy M 2002 Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. Journal of Biological Chemistry 277 3247-3257. (doi:10.1074/jbc.M106643200)
22. Hood JD & Cheresh JA 2002 Role of integrins in cell invasion and migration. Nature Reviews. Cancer 2 91-100. (doi:10.1038/nrc727)
23. Housa D, Housova J, Vernerova Z & Haluzik M 2006 Adipocytokines and cancer. Physiological Research 55 233-244.
24. Huang L & Li C 2000 Leptin: a multifunctional hormone. Cell Research 10 81-92. (doi:10.1038/sj.cr.7290038)
25. Insall RH & Machesky LM 2009 Actin dynamics at the leading edge: from simple machinery to complex networks. Developmental Cell 17 310-322. (doi:10.1016/j.devcel.2009.08.012)
26. Ishikawa M, Kitayama J & Nagawa H 2004 Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clinical Cancer Research 10 4325-4331. (doi:10.1158/1078-0432.CCR-03-0749)
27. Kaneko R, Tsuji N, Asanuma K, Tanabe H, Kobayashi D &Watanabe N 2007 Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer. Journal of Biological Chemistry 282 19273-19281. (doi:10.1074/jbc.M610350200)
28. Kanwar JR, Shen WP, Kanwar RK, Berg RW & Krissansen GW 2001 Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. Journal of the National Cancer Institute 93 1541-1552. (doi:10.1093/jnci/93.20.1541)
29. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T &Tanigawa N 1998 Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Research 58 5071-5074Pubitemid 28521163)
30. Kim PJ, Plescia J, Clevers H, Fearon ER & Altieri DC 2003 Survivin and molecular pathogenesis of colorectal cancer. Lancet 362 205-209. (doi:10.1016/S0140-6736(03)13910-4)
31. Klekotka PA, Santoro SA, Wang H & Zutter MM 2001 Specific residues within the a 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways. Journal of Biological Chemistry 276 32353-32361. (doi:10.1074/jbc.M101921200)
32. Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I & Ando S 2007 Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Research 67 3412-3421. (doi:10.1158/0008-5472.CAN-06-2890)
33. McKenzie JA, Liu T, Goodson AG & Grossman D 2010 Survivin enhances motility of melanoma cells by supporting Akt activation and a5 integrin upregulation. Cancer Research 70 7927-7937. (doi:10.1158/0008-5472.CAN-10-0194)
34. Miele L 2008 Rational targeting of Notch signaling in breast cancer. Expert Review of Anticancer Therapy 8 1197-1202. (doi:10.1586/14737140.8.8.1197)
35. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR et al. 2002 Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21 2613-2622. (doi:10.1038/sj.onc.1205353)
36. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, Nath AK, Pober JS & Altieri DC 2000 Control of apoptosis during angiogenesis by survivin expression in endothelial cells. American Journal of Pathology 156 393-398. (doi:10.1016/S0002-9440(10)64742-6)
37. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M & Yang L 2006 Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. Journal of Biological Chemistry 281 25903-25914. (doi:10.1074/jbc.M603414200)
38. Pinteaux E, Inoue W, Schmidt L, Molina-Holgado F, Rothwell NJ & Luheshi GN 2007 Leptin induces interleukin-1beta release from rat microglial cells through a caspase 1 independent mechanism. Journal of Neurochemistry 102 826-833. (doi:10.1111/j.1471-4159.2007.04559.x)
39. Purow BW, Sundaresan TK, Burdick MJ, Kefas BA, Comeau LD, Hawkinson MP, Su Q, Kotliarov Y, Lee J, Zhang W et al. 2008 Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis 29 918-925. (doi:10.1093/carcin/bgn079)
40. Ronchini C & Capobianco AJ 2001 Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Molecular and Cellular Biology 21 5925-5934. (doi:10.1128/MCB.21.17.5925-5934.2001)
41. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A &Shimosegawa T 2001 Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92 271-278. (doi:10.1002/1097-0142(20010715)92:2〈271::AID-CNCR1319〉3.0.CO;2-0)
42. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D &Anania FA 2007a Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Research 67 2497-2507. (doi:10.1158/0008-5472.CAN-06-3075)
43. Saxena NK, Vertino PM, Anania FA & Sharma D 2007b Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. Journal of Biological Chemistry 282 13316-13325. (doi:10.1074/jbc. M609798200)
44. Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM & Sharma D 2008 Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Research 68 9712-9722. (doi:10.1158/0008-5472.CAN-08-1952)
45. Sharma D, Saxena NK, Davidson NE & Vertino PM 2006a Restoration of tamoxifen sensitivity in estrogen receptornegative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Research 66 6370-6378. (doi:10.1158/0008-5472.CAN-06-0402)
46. Sharma D, Saxena NK, Vertino PM & Anania FA 2006b Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocrine-Related Cancer 13 629-640. (doi:10.1677/erc.1.01169)
47. Sieg DJ, Hauck CR & Schlaepfer DD 1999 Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. Journal of Cell Science 112 2677-2691Pubitemid 29429791)
48. Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S &Cerni C 2003 Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22 4266-4280. (doi:10.1038/sj.onc.1206509)
49. Stylianou S, Clarke RB & Brennan K 2006 Aberrant activation of notch signaling in human breast cancer. Cancer Research 66 1517-1525. (doi:10.1158/0008-5472.CAN-05-3054)
50. Taliaferro-Smith L, Nagalingam A, Zhong D, Zhou W, Saxena NK & Sharma D 2009 LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene 28 2621-2633. (doi:10.1038/onc.2009.129)
51. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, Benedetto C & Mussa A 2000 Leptin expression in colorectal and breast cancer patients. International Journal of Molecular Medicine 5 421-426.
52. Wang Q & Greene MI 2005 EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway. Experimental and Molecular Pathology 79 100-107. (doi:10.1016/j.yexmp.2005.05.002)
53. Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC et al. 2002 Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nature Medicine 8 979-986. (doi:10.1038/nm754)
54. Wu F, Stutzman A & Mo YY 2007 Notch signaling and its role in breast cancer. Frontiers in Bioscience 12 4370-4383. (doi:10.2741/2394)
55. Xu ZX, Zhao RX, Ding T, Tran TT, Zhang W, Pandolfi PP &Chang KS 2004 Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression. Journal of Biological Chemistry 279 1838-1844. (doi:10.1074/jbc. M310987200)
56. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ &Boman BM 2001 Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Research 61 8664-8667Pubitemid 34013874)
57. Zhang B, Gu F, She C, Guo H, Li W, Niu R, Fu L, Zhang N &Ma Y 2009 Reduction of Akt2 inhibits migration and invasion of glioma cells. International Journal of Cancer 125 585-595. (doi:10.1002/ijc.24314)
58. Zheng DQ, Woodard AS, Tallini G & Languino LR 2000 Substrate specificity of a(v)b(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. Journal of Biological Chemistry 275 24565-24574. (doi:10.1074/jbc.M002646200)